Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro
about
Inhalation exposure to carbon nanotubes (CNT) and carbon nanofibers (CNF): methodology and dosimetryImpacts of chemical modification on the toxicity of diverse nanocellulose materials to developing zebrafishThe carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in ratsCritical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epitheliumPulmonary instillation of MWCNT increases lung permeability, decreases gp130 expression in the lungs, and initiates cardiovascular IL-6 transsignalingAdsorption of surfactant protein D from human respiratory secretions by carbon nanotubes and polystyrene nanoparticles depends on nanomaterial surface modification and sizePulmonary instillation of multi-walled carbon nanotubes promotes coronary vasoconstriction and exacerbates injury in isolated heartsInhalation of silver nanomaterials--seeing the risksStealth nanotubes: strategies of shielding carbon nanotubes to evade opsonization and improve biodistributionAn in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterialsStatic and Dynamic Microscopy of the Chemical Stability and Aggregation State of Silver Nanowires in Components of Murine Pulmonary SurfactantPulmonary surfactant is indispensable in order to simulate the in vivo situationSurfactant protein A (SP-A) inhibits agglomeration and macrophage uptake of toxic amine modified nanoparticlesPhysicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein coronaExposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interfacePulmonary surfactant augments cytotoxicity of silica nanoparticles: Studies on an in vitro air-blood barrier modelHuman epithelial cells exposed to functionalized multiwalled carbon nanotubes: interactions and cell surface modifications.Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and type-II epithelial cells.Comparability of in vitro tests for bioactive nanoparticles: a common assay to detect reactive oxygen species as an exampleRole of oxidative stress in carbon nanotube-generated health effects.Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages.Weathering of a carbon nanotube/epoxy nanocomposite under UV light and in water bath: impact on abraded particles.Apoptotic, inflammatory, and fibrogenic effects of two different types of multi-walled carbon nanotubes in mouse lung.Exposure and emission measurements during production, purification, and functionalization of arc-discharge-produced multi-walled carbon nanotubes.Exposure to silver nanoparticles affects viability and function of natural killer cells, mostly via the release of ions.Understanding the mutual impact of interaction between hydrophobic nanoparticles and pulmonary surfactant monolayer.Pulmonary surfactant protein SP-D opsonises carbon nanotubes and augments their phagocytosis and subsequent pro-inflammatory immune response.Carboxylic acid functionalization prevents the translocation of multi-walled carbon nanotubes at predicted environmentally relevant concentrations into targeted organs of nematode Caenorhabditis elegans.Monocyte adhesion induced by multi-walled carbon nanotubes and palmitic acid in endothelial cells and alveolar-endothelial co-cultures.The role of natural processes and surface energy of inhaled engineered nanoparticles on aggregation and corona formation.Biological Effects in Lung Cells In Vitro of Exhaust Aerosols from a Gasoline Passenger Car With and Without Particle FilterThe Role of the Protein Corona in Fiber Structure-Activity Relationships
P2860
Q23913295-29176410-5978-42B4-AF93-7E13F3A57B9BQ26343230-3A14C995-BB5F-4B09-85BA-EB7E12D4EAB4Q28382993-3E23A75D-CCDC-461D-99E7-093284E2B810Q28383130-764E9D54-D1EA-44EC-8044-D93BE83EC488Q28384533-36BF2EC2-CD72-4A1C-B9E6-B647E192319CQ28384891-CFF3777A-749E-4DEF-92CB-E8E7A181FE31Q28385058-CE73720D-B6ED-4D40-B7FF-B65D986EF3FBQ28385452-3EC73685-5CC6-41B9-A215-86E8FA5FF951Q28386169-CCD70167-0C83-4B4D-A421-B169751DDAE9Q28388825-73A5CAA4-C126-4B12-BD62-AC7187CF9E8DQ28389007-353EC265-FFC6-4033-8AE9-2F26469E3631Q28396472-749CC6D0-F12D-46D5-B199-5D5A9DE393CEQ28397412-4195EA01-8272-4CE7-9DBA-4E3A687F05A1Q29248541-55AF5FDE-35FC-4E68-A70F-DB7EEFAE6DE2Q29248681-1C0659D0-DEF3-474F-A13F-84FD6CD99906Q35589716-80170F70-D829-4E53-95D4-A91193C61C6BQ35599815-EC394974-DA71-4931-83CB-3F07C8FBD688Q36612289-4853CA93-F305-45F2-BCB8-7B21047026E2Q37421001-04181275-28EA-42B7-842E-7F9348152D5BQ38248454-67FB735A-870D-40DD-BC8B-7748F6875FBBQ38782417-214E9170-171D-4C97-9C9B-9993E3DBCD39Q38826079-E8BA7F54-65D7-45A8-A4AF-DB5CD510E373Q39012172-4EC61464-0E02-40E7-A306-CC44E946729EQ39279927-1BFA3060-3B1F-4734-8CBD-61DDF9DAC3A4Q40117478-3999FAC9-7820-48C6-B05E-5A04A49E4C2CQ44454078-72A943CB-9E3A-4150-9E73-539C30AF379EQ45049186-CA2E9C01-27EE-4844-9C11-9B81597DFBDAQ46022747-8C2A3ECD-9C26-489A-B4A0-AC4DEDE5135FQ46715803-CAC3D324-0A5F-4ED9-A729-2C7F2A6DF6DFQ47141783-6F2E8568-5EC9-48FA-A211-75BB043A173EQ58493086-DA26238A-3494-47AA-9EA6-A7D5B087B1BFQ58493134-6A4B69B8-B323-4DC8-841A-40FF7F2EC81A
P2860
Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@ast
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@en
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@nl
type
label
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@ast
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@en
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@nl
prefLabel
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@ast
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@en
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@nl
P2093
P2860
P50
P356
P1476
Pulmonary surfactant coating o ...... nflammatory potential in vitro
@en
P2093
Harald F Krug
Liliane Diener
Michael Gasser
Peter Gehr
Peter Wick
P2860
P2888
P356
10.1186/1743-8977-9-17
P407
P577
2012-05-24T00:00:00Z
P5875
P6179
1020076214